Harel Insurance Investments & Financial Services’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Sell |
157,772
-216,210
| -58% | -$2.96M | 0.02% | 144 |
|
|
2025
Q1 | $4.14M | Sell |
373,982
-89,285
| -19% | -$987K | 0.05% | 123 |
|
|
2024
Q4 | $4.93M | Hold |
463,267
| – | – | 0.08% | 93 |
|
|
2024
Q3 | $5.88M | Sell |
463,267
-298
| -0.1% | -$3.78K | 0.1% | 68 |
|
|
2024
Q2 | $7.78M | Sell |
463,565
-209,922
| -31% | -$3.52M | 0.15% | 66 |
|
|
2024
Q1 | $10.1M | Sell |
673,487
-196,558
| -23% | -$2.95M | 0.2% | 54 |
|
|
2023
Q4 | $13.1M | Sell |
870,045
-149
| -0% | -$2.24K | 0.23% | 63 |
|
|
2023
Q3 | $12.2M | Sell |
870,194
-155,373
| -15% | -$2.18M | 0.24% | 66 |
|
|
2023
Q2 | $10.6M | Sell |
1,025,567
-301
| -0% | -$3.12K | 0.26% | 49 |
|
|
2023
Q1 | $9.48M | Buy |
1,025,868
+308
| +0% | +$2.85K | 0.19% | 72 |
|
|
2022
Q4 | $9.1M | Sell |
1,025,560
-23
| -0% | -$204 | 0.2% | 65 |
|
|
2022
Q3 | $8.53M | Sell |
1,025,583
-28
| -0% | -$233 | 0.21% | 77 |
|
|
2022
Q2 | $8.4M | Sell |
1,025,611
-22
| -0% | -$180 | 0.18% | 84 |
|
|
2022
Q1 | $8.93M | Sell |
1,025,633
-42
| -0% | -$366 | 0.15% | 86 |
|
|
2021
Q4 | $9.75M | Buy |
+1,025,675
| New | +$9.75M | 0.18% | 70 |
|
|
2019
Q3 | – | Sell |
-3,000
| Closed | -$108K | – | 573 |
|
|
2019
Q2 | $108K | Buy |
3,000
+1,000
| +50% | +$36K | 0.01% | 238 |
|
|
2019
Q1 | $74K | Buy |
2,000
+1,000
| +100% | +$37K | ﹤0.01% | 238 |
|
|
2018
Q4 | $43K | Sell |
1,000
-1,600
| -62% | -$68.8K | ﹤0.01% | 311 |
|
|
2018
Q3 | $123K | Hold |
2,600
| – | – | 0.01% | 253 |
|
|
2018
Q2 | $129K | Buy |
+2,600
| New | +$129K | 0.01% | 231 |
|